NNovo Nordisk Read More AMGN’s MariTide: Can Convenience Drive its Obesity Market Share?2026-09-04 Amgen’s AMGN key pipeline candidate MariTide is a closely watched drug in the obesity market. The drug can…
NNovo Nordisk Read More In the Weight-Loss Wars, Novo’s Obesity Pill Is Pulling Way Ahead of Lilly’s2026-07-16 The launch of weight-loss pills is the hottest battle in pharma. So far, Eli Lilly LLY 1.15%increase; up…